tallózása szerző szerint "Dobos J"

1-7 / 7

Apelin expression in human non-small cell lung cancer: Role in angiogenesis and prognosis

Berta, Judit; Kenessey, István; Dobos J; Tóvári, József; Klepetko W; Ankersmit HJ; Hegedűs, Balázs; Rényi-Vámos, Ferenc István; Varga, János; Lorincz Zs; Paku, Sándor; Ostoros, Gyula; Rózsás, Anita; Tímár, József; Döme, Balázs (2010)
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.

Garamvölgyi Rita; Dobos J; Sipos A; Boros S; Illyes E; Kéri György; Őrfi László (2016)

Melanoma is an aggressive form of skin cancer and it is generally associated with poor prognosis in patients with late-stage disease. Due to the increasing occurrence of melanoma, there is a need for the development of ...
Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells

Dobos J; Kenessey, István; Tímár, József; Ladányi, Andrea (2011)
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma.

Kenessey I; Keszthelyi M; Krámer ZF,; Berta J; Ádám A; Dobos J; Mildner M; Flachner B; Cseh S; Barna G; Szokol B; Őrfi L; Kéri G; Döme B; Klepetko W; Tímár J; Tóvári J (2010)

The hepatocyte growth factor/scatter factor (HGF/SF) tyrosine kinase (TK) receptor c-Met plays a crucial role in the development of the invasive phenotype of tumors and thus represents an attractive candidate for targeted ...
Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells.

Garay, Tamás; Kenessey, István; Molnár, Eszter; Juhasz E; Réti, Andrea; Laszlo V; Rozsas A; Dobos J; Döme, Balázs; Berger W; Klepetko W; Tóvári, József; Tímár, József; Hegedűs, Balázs (2015)

While targeted therapy brought a new era in the treatment of BRAF mutant melanoma, therapeutic options for non-BRAF mutant cases are still limited. In order to explore the antitumor activity of prenylation inhibition we ...
Prognostic impact of B-cell density in cutaneous melanoma

Ladányi, Andrea; Kiss J; Mohos, Anita; Somlai, Beáta; Liszkay G,; Gilde K; Fejős Zs; Gaudi I; Dobos J; Tímár, József (2011)
Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations

Garay, Tamás; Molnár, Eszter; Juhasz E; Laszlo V; Barbai, Tamás; Dobos J; Schelch K; Pirker C; Grusch M; Berger W; Tímár, József; Hegedűs, Balázs (2015)

BRAF and NRAS are the two most frequent oncogenic driver mutations in melanoma and are pivotal components of both the EGF and FGF signaling network. Accordingly, we investigated the effect of BRAF and NRAS oncogenic mutation ...

1-7 / 7

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Dobos J"

DSpace/Manakin Repository

tallózása szerző szerint "Dobos J"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem